Related Experiment Video
Updated: Sep 18, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Sex-Specific Differences in Management and Outcomes of Cardiogenic Shock Patients With and Without Ischemic
Ik Hyun Park1, Chang Hoon Kim2, Woo Jin Jang3
1Department of Cardiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Insights
Sex does not significantly impact cardiogenic shock (CS) management or mortality, regardless of whether ischemic cardiomyopathy (ICMP) is present. This study found comparable outcomes for both male and female patients with CS.
Area of Science:
- Cardiology
- Clinical Research
- Sex-Based Medicine
Background:
- Limited data exists on sex-based differences in cardiogenic shock (CS) management and outcomes.
- Investigating these differences is crucial for personalized patient care.
- Stratification by underlying etiology, such as ischemic cardiomyopathy (ICMP), is necessary.
Purpose of the Study:
- To determine if clinical management and outcomes in patients with CS differ between sexes.
- To analyze these differences stratified by CS etiology (ICMP vs. non-ICMP).
Main Methods:
- Analysis of 1,247 CS patients from the multicenter RESCUE registry.
- Stratification by sex and CS etiology (ICMP and non-ICMP).
- Utilized multivariable Cox proportional hazards models and propensity-score matching for analysis.
Main Results:
- Among ICMP patients, females underwent coronary angiography less frequently, but revascularization success rates were similar.
- In-hospital 30-day mortality was comparable between sexes in both ICMP and non-ICMP groups.
- 12-month mortality risk also remained similar between sexes across both etiological groups.
Conclusions:
- No significant sex-based differences were observed in the management of CS.
- In-hospital and 12-month mortality rates were comparable between females and males with CS.
- These findings hold true irrespective of the underlying etiology of CS.
Background And Objectives:
Comprehensive data on sex-based differences in the management and outcomes of patients with and without ischemic cardiomyopathy (ICMP) presenting with cardiogenic shock (CS) remain limited. This study aimed to investigate whether clinical management and outcomes differ by sex among CS patients, stratified by underlying etiology.
Methods:
We analyzed 1,247 CS patients from the RESCUE registry, a multicenter observational cohort, stratified by sex and CS etiology: ICMP (females: 276, males: 730) and non-ICMP (females: 111, males: 130). Primary outcomes included in-hospital and 12-month mortality. Multivariable Cox proportional hazards models and propensity-score matching were used to adjust for confounding factors.
Results:
Among ICMP patients, females were less likely to undergo coronary angiography (p=0.001), although rates of successful revascularization were similar between sexes (p=0.982). In-hospital 30-day mortality did not differ significantly between females and males in either the ICMP cohort (37.1% vs. 29.5%; adjusted hazard ratio [HR], 0.93; 95% confidence interval [CI], 0.63-1.39; p=0.737) or the non-ICMP cohort (28.3% vs. 25.6%; adjusted HR, 1.23; 95% CI, 0.68-2.22; p=0.493). At 12 months, mortality risk remained comparable between sexes in both ICMP (46.4% vs. 37.1%; adjusted HR, 0.82; 95% CI, 0.57-1.17; p=0.274) and non-ICMP groups (40.1% vs. 41.3%; adjusted HR, 0.91; 95% CI, 0.56-1.45; p=0.685). These findings were consistent after propensity-score matching.
Conclusions:
There was no significant difference in management, 12-month or in-hospital mortality between females and males, irrespective of the etiology of CS.
Trial Registration:
ClinicalTrials.gov Identifier: NCT02985008.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

